Preparation method of Levamlodipine besylate tablet
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] (1) Formula: (calculated on the basis of 1,000,000 plain tablets)
[0022]
[0023] The filler is: microcrystalline cellulose, calcium hydrogen phosphate
[0024] The disintegrant is sodium carboxymethyl starch, the lubricant is magnesium stearate
[0025] The above raw and auxiliary materials are all sold in the market.
[0026] (2) method:
[0027] Firstly, levamlodipine besylate and calcium hydrogen phosphate are pulverized through a 100-mesh sieve, microcrystalline cellulose and carboxymethyl starch sodium are pulverized through a 80-mesh sieve, and then mixed together. Then, mix evenly through a fluidized bed one-step granulator, and the air volume during granulation is 854-964m3 / h; the spray speed is 75rpm; the spray pressure is 1.7bar. Dry, the air volume is 854~964m when dry 3 / h; material temperature 20℃~60℃; set inlet air temperature 40℃~80℃, control moisture 1.5~2.5%. After passing through the 24-mesh sieve, add lubricant and mix evenly in the mixer. ...
Embodiment 2
[0029] The stability of the levamlodipine besylate that embodiment 1 method makes, dissolution rate investigation test:
[0030] 1. Prescription ingredients:
[0031] According to the compatibility test method of excipients, calcium hydrogen phosphate (CaHPO4), lactose and levamlodipine besylate (main drug) were mixed in a ratio of 5:1 respectively, and the prepared samples were respectively placed in an oven at 60° C. 0 day, 5 days, and 10 days to investigate the changes of related substances. To investigate the compatibility of excipients and main ingredients.
[0032] Table 1 Prescription screening test results
[0033]
[0034] The above results show that the application of calcium hydrogen phosphate is more conducive to controlling the amount of related substances in levamlodipine besylate tablets than lactose.
[0035] 2 Stability test results
[0036] (1). Illumination test Take levamlodipine besylate tablets (prepared in Example 1), put them in an open petri dis...
Embodiment 3
[0046] Example 3 The key indicators of the levamlodipine besylate tablets prepared by the method in Example 1 were compared with those of the "Shihuida" product purchased in the market.
[0047] According to the following method, compare the key indicators of commercially available products and self-developed products, that is, related substances, dissolution rate, and content.
[0048] (1) the levamlodipine besylate sheet that embodiment 1 method makes
[0049] 【Related Substances】Keep away from light. Take an appropriate amount of this product’s fine powder (approximately equivalent to levamlodipine 15 mg), accurately weigh it, put it in a 25ml measuring bottle, add an appropriate amount of mobile phase, sonicate to dissolve levamlodipine, let it cool, and dilute to the mark with mobile phase , Shake up, filter, get the continued filtrate as the test solution; precision measure 1ml, put in a 100ml measuring bottle, dilute to the mark with mobile phase, shake up, as the cont...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com